S&P 500   5,053.38 (-0.17%)
DOW   37,808.60 (+0.19%)
QQQ   431.69 (+0.15%)
AAPL   169.36 (-1.93%)
MSFT   416.14 (+0.60%)
META   500.93 (+0.14%)
GOOGL   154.89 (+0.02%)
AMZN   183.65 (+0.02%)
TSLA   156.52 (-3.07%)
NVDA   873.98 (+1.62%)
AMD   163.23 (+1.82%)
NIO   3.84 (-1.29%)
BABA   70.03 (-0.84%)
T   16.03 (-1.29%)
F   12.18 (-0.41%)
MU   121.04 (-0.27%)
GE   155.81 (+1.37%)
CGC   6.84 (-2.01%)
DIS   114.00 (+0.93%)
AMC   2.86 (+15.79%)
PFE   25.82 (-0.35%)
PYPL   63.92 (+0.65%)
XOM   118.42 (-1.05%)
S&P 500   5,053.38 (-0.17%)
DOW   37,808.60 (+0.19%)
QQQ   431.69 (+0.15%)
AAPL   169.36 (-1.93%)
MSFT   416.14 (+0.60%)
META   500.93 (+0.14%)
GOOGL   154.89 (+0.02%)
AMZN   183.65 (+0.02%)
TSLA   156.52 (-3.07%)
NVDA   873.98 (+1.62%)
AMD   163.23 (+1.82%)
NIO   3.84 (-1.29%)
BABA   70.03 (-0.84%)
T   16.03 (-1.29%)
F   12.18 (-0.41%)
MU   121.04 (-0.27%)
GE   155.81 (+1.37%)
CGC   6.84 (-2.01%)
DIS   114.00 (+0.93%)
AMC   2.86 (+15.79%)
PFE   25.82 (-0.35%)
PYPL   63.92 (+0.65%)
XOM   118.42 (-1.05%)
S&P 500   5,053.38 (-0.17%)
DOW   37,808.60 (+0.19%)
QQQ   431.69 (+0.15%)
AAPL   169.36 (-1.93%)
MSFT   416.14 (+0.60%)
META   500.93 (+0.14%)
GOOGL   154.89 (+0.02%)
AMZN   183.65 (+0.02%)
TSLA   156.52 (-3.07%)
NVDA   873.98 (+1.62%)
AMD   163.23 (+1.82%)
NIO   3.84 (-1.29%)
BABA   70.03 (-0.84%)
T   16.03 (-1.29%)
F   12.18 (-0.41%)
MU   121.04 (-0.27%)
GE   155.81 (+1.37%)
CGC   6.84 (-2.01%)
DIS   114.00 (+0.93%)
AMC   2.86 (+15.79%)
PFE   25.82 (-0.35%)
PYPL   63.92 (+0.65%)
XOM   118.42 (-1.05%)
S&P 500   5,053.38 (-0.17%)
DOW   37,808.60 (+0.19%)
QQQ   431.69 (+0.15%)
AAPL   169.36 (-1.93%)
MSFT   416.14 (+0.60%)
META   500.93 (+0.14%)
GOOGL   154.89 (+0.02%)
AMZN   183.65 (+0.02%)
TSLA   156.52 (-3.07%)
NVDA   873.98 (+1.62%)
AMD   163.23 (+1.82%)
NIO   3.84 (-1.29%)
BABA   70.03 (-0.84%)
T   16.03 (-1.29%)
F   12.18 (-0.41%)
MU   121.04 (-0.27%)
GE   155.81 (+1.37%)
CGC   6.84 (-2.01%)
DIS   114.00 (+0.93%)
AMC   2.86 (+15.79%)
PFE   25.82 (-0.35%)
PYPL   63.92 (+0.65%)
XOM   118.42 (-1.05%)

Genmab A/S (GMAB) SEC Filings & 10K Form

$29.55
+0.04 (+0.14%)
(As of 01:40 PM ET)

Recent Genmab A/S SEC Filings

DateFilerForm TypeView
04/15/2024
12:17 PM
GENMAB A/S (Filer)
Genmab A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/08/2024
12:41 PM
GENMAB A/S (Filer)
Genmab A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/03/2024
5:19 AM
GENMAB A/S (Filer)
Genmab A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/02/2024
8:10 AM
GENMAB A/S (Filer)
Genmab A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/21/2024
2:28 PM
GENMAB A/S (Filer)
Genmab A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/18/2024
3:37 PM
GENMAB A/S (Filer)
Genmab A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/15/2024
8:46 AM
GENMAB A/S (Filer)
Genmab A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/13/2024
4:10 PM
GENMAB A/S (Filer)
Genmab A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/13/2024
10:34 AM
GENMAB A/S (Filer)
Genmab A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/11/2024
12:43 PM
GENMAB A/S (Filer)
Genmab A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/04/2024
12:50 PM
GENMAB A/S (Filer)
Genmab A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/04/2024
12:26 PM
GENMAB A/S (Filer)
Genmab A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/29/2024
10:47 AM
GENMAB A/S (Filer)
Genmab A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/28/2024
10:06 AM
GENMAB A/S (Filer)
Genmab A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/26/2024
11:19 AM
GENMAB A/S (Filer)
Genmab A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/26/2024
9:40 AM
GENMAB A/S (Filer)
Genmab A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/20/2024
10:30 AM
GENMAB A/S (Filer)
Genmab A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/14/2024
2:42 PM
GENMAB A/S (Filer)
Genmab A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/14/2024
12:49 PM
GENMAB A/S (Filer)
Genmab A/S (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
02/14/2024
11:30 AM
GENMAB A/S (Filer)
Genmab A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/02/2024
1:18 PM
BlackRock Inc. (Filed by)
GENMAB A/S (Subject)
Genmab A/S (Subject)
Form SC 13G/A
01/31/2024
10:17 AM
GENMAB A/S (Filer)
Genmab A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/23/2024
8:04 AM
GENMAB A/S (Filer)
Genmab A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/22/2024
7:01 PM
GENMAB A/S (Filer)
Genmab A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/03/2024
7:35 AM
GENMAB A/S (Filer)
Genmab A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/13/2023
10:46 AM
GENMAB A/S (Filer)
Genmab A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
12/01/2023
12:15 PM
GENMAB A/S (Filer)
Genmab A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/21/2023
3:51 PM
GENMAB A/S (Filer)
Genmab A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/09/2023
9:15 AM
GENMAB A/S (Filer)
Genmab A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/08/2023
11:24 AM
GENMAB A/S (Filer)
Genmab A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/07/2023
10:12 AM
GENMAB A/S (Filer)
Genmab A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/17/2023
7:22 AM
GENMAB A/S (Filer)
Genmab A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/05/2023
9:35 AM
GENMAB A/S (Filer)
Genmab A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/28/2023
3:15 PM
GENMAB A/S (Filer)
Genmab A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/25/2023
7:53 AM
GENMAB A/S (Filer)
Genmab A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/13/2023
8:59 AM
GENMAB A/S (Filer)
Genmab A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/12/2023
2:05 PM
GENMAB A/S (Filer)
Genmab A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/05/2023
8:12 AM
GENMAB A/S (Filer)
Genmab A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/16/2023
12:44 PM
GENMAB A/S (Filer)
Genmab A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/15/2023
2:06 PM
GENMAB A/S (Filer)
Genmab A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/03/2023
10:16 AM
GENMAB A/S (Filer)
Genmab A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
Can't believe it's happening again (Ad)

One of the single most unique and powerful events in the markets is coming in the next two months. It’s scheduled for April 22, 2024. But investors are moving now to get ahead of what’s coming… driving up prices of one asset dramatically. And you should do the same.

We explain how this event works in full right here.
07/21/2023
8:08 AM
GENMAB A/S (Filer)
Genmab A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/20/2023
8:00 AM
GENMAB A/S (Filer)
Genmab A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/21/2023
10:18 AM
GENMAB A/S (Filer)
Genmab A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/20/2023
11:57 AM
GENMAB A/S (Filer)
Genmab A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/08/2023
4:27 PM
GENMAB A/S (Filer)
Genmab A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/01/2023
3:24 PM
GENMAB A/S (Filer)
Genmab A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/31/2023
8:44 AM
GENMAB A/S (Filer)
Genmab A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/24/2023
9:46 AM
GENMAB A/S (Filer)
Genmab A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/23/2023
2:26 PM
GENMAB A/S (Filer)
Genmab A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/19/2023
11:48 AM
GENMAB A/S (Filer)
Genmab A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/10/2023
10:23 AM
GENMAB A/S (Filer)
Genmab A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/24/2023
7:58 AM
GENMAB A/S (Filer)
Genmab A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/20/2023
7:18 PM
GENMAB A/S (Filer)
Genmab A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/18/2023
9:20 AM
GENMAB A/S (Filer)
Genmab A/S (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:GMAB) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners